Contributors. Preface; A.R. Hauser, J. Rello. Series Preface; J. Rello. 1. Pseudomonas aeruginosa Infections in Specific Types of Patients and Clinical Settings; M.E. Stryjewski, D.J. Sexton. 2. The Spectrum of Pseudoinonas aeruginosa Disease; J. Roig, M. Sabria. 3. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa: North American Perspective; G.W. Waterer, R.G. Wunderink. 4. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa: European Perspective; E. Diaz, J. Rello, J. Vallès. 5. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis: North American Perspective; D.J. Davidson, A.J. Currie, D.P. Speert. 6. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis: European Perspective; M. Bosque, Ò. Asensio. 7. Pseudomonas aeruginosa Infections in Cancer Patients; K.V.I. Rolston. 8. Treatment of Serious Pseudomonas aeruginosa Infections: North American Perspective; P. Voirol, B.J. Guglielmo. 9. Treatment of Serious Pseudomonas aeruginosa Infections: European Perspective; G. Höffken. 10. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit: North American Perspective; W.R. Jarvis. 11. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit: European Perspective; D. Talon, X. Bertrand. 12. New Perspectives on Prevention and Management of Pseudomonas aeruginosa Infections; K.P. Rumbaugh, T. Sawa, J.P. Wiener-Kronish. 13.Molecular Pathogenesis of Acute Pseudomonas aeruginosa Infections; J.N. Engel. Index.
Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies.
This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe.